These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1810261)

  • 1. Effects of a new aldose reductase inhibitor on diabetic complications in rats.
    Gervasi GB; Bartoli C; Catalani R; Farina C; Carpita G; Caccia G; Ammannati P
    Arzneimittelforschung; 1991 Nov; 41(11):1160-3. PubMed ID: 1810261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract.
    Ao S; Kikuchi C; Ono T; Notsu Y
    Invest Ophthalmol Vis Sci; 1991 Nov; 32(12):3078-83. PubMed ID: 1834606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonosmotic diabetic cataracts.
    Malone JI; Lowitt S; Cook WR
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xanthone-2-carboxylic acid effect on lens growth, hydration and proteins during diabetic cataract development.
    Beyer-Mears A; Cruz E; Nicolas-Alexandre J; Varagiannis E
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):166-76. PubMed ID: 6817723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new approach against sugar cataract through aldose reductase inhibitors.
    Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U
    Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altering the course of cataracts in diabetic rats.
    Fukushi S; Merola LO; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1980 Mar; 19(3):313-5. PubMed ID: 6766909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished proteinuria in diabetes mellitus by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E; Edelist T; Varagiannis E
    Pharmacology; 1986; 32(1):52-60. PubMed ID: 3080763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of lens aldose reductase activity by nitric oxide.
    Srivastava S; Tammali R; Chandra D; Greer DA; Ramana KV; Bhatnagar A; Srivastava SK
    Exp Eye Res; 2005 Dec; 81(6):664-72. PubMed ID: 15967436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of Ganoderma applanatum on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
    Jung SH; Lee YS; Shim SH; Lee S; Shin KH; Kim JS; Kim YS; Kang SS
    Phytother Res; 2005 Jun; 19(6):477-80. PubMed ID: 16114079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.
    Kador PF; Inoue J; Secchi EF; Lizak MJ; Rodriguez L; Mori K; Greentree W; Blessing K; Lackner PA; Sato S
    Exp Eye Res; 1998 Aug; 67(2):203-8. PubMed ID: 9733586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zopolrestat prevention of proteinuria, albuminuria and cataractogenesis in diabetes mellitus.
    Beyer-Mears A; Mistry K; Diecke FP; Cruz E
    Pharmacology; 1996 May; 52(5):292-302. PubMed ID: 8807673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of ponalrestat on sorbitol levels in the lens of obese and diabetic mice.
    Vicario PP; Slater EE; Saperstein R
    Biochem Int; 1989 Sep; 19(3):553-61. PubMed ID: 2510726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
    Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
    Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a new aldose reductase inhibitor on various tissues in vitro.
    Terashima H; Hama K; Yamamoto R; Tsuboshima M; Kikkawa R; Hatanaka I; Shigeta Y
    J Pharmacol Exp Ther; 1984 Apr; 229(1):226-30. PubMed ID: 6423811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIOM-79 inhibits aldose reductase activity and cataractogenesis in Zucker diabetic fatty rats.
    Kim J; Kim CS; Sohn E; Lee YM; Kim JS
    J Pharm Pharmacol; 2011 Oct; 63(10):1301-8. PubMed ID: 21899546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens.
    Obrosova IG; Stevens MJ
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):680-8. PubMed ID: 10067971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical localization for aldose reductase in diabetic lenses.
    Akagi Y; Kador PF; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1987 Jan; 28(1):163-7. PubMed ID: 3100473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical detection of glycated beta- and gamma-crystallins in lens and their circulating autoantibodies (IgG) in streptozocin induced diabetic rat.
    Ranjan M; Nayak S; Rao BS
    Mol Vis; 2006 Sep; 12():1077-85. PubMed ID: 17093392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldose reductase in early streptozotocin-induced diabetic rat lens.
    Garadi R; Lou MF
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2370-5. PubMed ID: 2509397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AL-1576, an aldose reductase inhibitor (ARI), did not prevent the decrease of norepinephrine turnover in diabetic rats.
    Yen TT; Fuller RW; Broderick CL; Hemrick-Luecke SK; Perry KW
    Res Commun Chem Pathol Pharmacol; 1988 Aug; 61(2):257-60. PubMed ID: 3141993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.